References
- Greendale GA, Lee NP, Arriola ER. The menopause. Lancet 1999;353:571–580
- Dennerstein L, Dudley EC, Hopper JL, Guthrie, JR, Burger, HG. A prospective population-based study of menopausal symptoms. Obstet Gynecol 2000;96:351–358
- Brown WJ, Mischra GD, Dobson A. Changes in physical symptoms during the menopause trnaisition. Int J Behav Med 2002;9:53–67
- Szoeke CE, Cicuttini FM, Guthrie JR, Dennerstein L. The relationship of reports of aches and joint pains to the menopausal transition: a longitudinal study. Climacteric 2008;11:55–62
- Dugan SA, Powell LH, Kravitz HM, Everson-Rose SA Karavolos K, Luborsky J. Musculoskeletal pain and menopausal status. Clin J Pain 2006;22:325–331
- Goldberg MS, Scott SC, Mayo NE. A review of the association between cigarette smoking and the development of nonspecific back pain and related outcome. Spine 2000;25:995–1014
- Silman AJ, Ferry S, Papeageorgiou AC, et al Number of children as risk factor for low back pain in men and women. Arthritis Rheum 1995;38:1232–1235
- Dugan SA, Everson-Rose SA, Karavolos K, Sternfeld B, Wesley D, Powell LH. The impact o f physical activity level on SF-36 Role-physical and Bodily Pain Indices in midlife women. J Phys Activity Health 2009;6:33–42
- Silverstein B. Gender difference in the prevalence of clinical depression: the role played by depression associated with somatic symptoms. Am J Psychol 1999;156:480–482
- Freeman EW, Sammel MD, Oin H, et al Symptoms associated with menopausal transition and reproductive hormones in midlife women. Obstet Gynecol 2007;110:230–240
- Halbreich U, Kan L. Atypical depression, somatic depression, and anxious depression in women: are they gender-preferred phenotypes? J Affect Disord 2007;102:245–258
- Ockene JK, Barad DH, Cochrane BB, et al Symptom experience after discontinuing use of estrogen plus progestin. JAMA 2005;294:183–193
- Felson DT, Cummings SR. Aromatase inhibitors and the syndrome of arthralgias with estrogen deprivation. Arthritis Rheum 2005;52:2594–2598
- Woods NF, Mitchell ES, Percival DB, Smith-DiJulio K. Is the menopausal transition stressful? Observations of perceived stress from the Seattle Midlife Women's Health Study. Menopause 2009;16:90–97
- Woods NF, Smith-DiJulio K, Percival DB, Tao EY, Taylor, HJ, Mitchell ES. Symptoms during the menopausal transition and early postmenopause and their relation to endocrine levels over time: observations from the Seattle Midlife Women's Health Study. J Women's Health 2007;16:667–677
- Gold EB, Sternfeld B, Kelsey JL, et al Relation of demographic and lifestyle factors to symptoms in a multi-racial/ethnic population of women 40–55 years of age. Am J Epidemiol 2000;152:463–473
- Obermeyer CM, Reher D, Saliba M. Symptoms, menopause status, and country differences: a comparative analysis from DAMES. Menopause 2007;14:788–797
- Soules MR, Sherman S, Parrott E, et al Executive summary: Stages of Reproductive Aging Workshop (STRAW). Fertil Steril 2001;76:874–878
- Mitchell ES, Woods NF, Mariella A. Three stages of the menopausal transition from the Seattle Midlife Women's Health Study: toward a more precise definition. Menopause 2000;7:334–349
- Harlow SD, Cain K, Crawford S, et al Evaluation of four proposed bleeding criteria for the onset of late menopausal transition. J Clin Endocrinol Metab 2006;91:3432–3438
- Harlow SD, Mitchell ES, Crawford S, Nan B, Little R, Taffe J; ReSTAGE Collaboration. The ReSTAGE Collaboration: defining optimal bleeding criteria for onset of early menopausal transition. Fertil Steril 2008;89:129–140
- Harlow SD, Crawford S, Dennerstein L, Burger HG, Mitchell ES, Sowers MF; ReSTAGE Collaboration. Recommendations from a multi-study evaluation of proposed criteria for staging reproductive aging. Climacteric 2007;10:112–119
- Chiazze L Jr, Brayer FT, Macisco JJ Jr, Parker MP, Duffy BJ. The length and variability of the human menstrual cycle. JAMA 1968;203:377–380
- Denari JH, Farinati Z, Casas PR, Oliva A. Determination of ovarian function using first morning urine steroid assays. Obstet Gynecol 1981;58:5–9
- Stanczyk FZ, Miyakawa I, Goebelsmann U. Direct radioimmunoassay of urinary estrogen and pregnanediol glucuronides during the menstrual cycle. Am J Obstet Gynecol 1980;137:443–450
- O'Connor KA, Brindle E, Holman DJ, et al Urinary estrone conjugate and pregnanediol 3-glucuronide enzyme immunoassays for population research. Clin Chem 2003; 49:1139–1148
- Baker TE, Jennison KIM, Kellie AE. The direct radioimmunoassay of oestrogen glucuronides in human female urine. Biochem J 1979;177:729–738
- Ferrell RJ, O'Connor KA, Holman DJ. Monitoring the transition to menopause in a five year prospective study: aggregate and individual changes in steroid hormones and menstrual cycle lengths with age. Menopause 2005;12:567–577
- O'Connor KA, Brindle E, Shofer JB, et al Statistical correction for non-parallelism in a urinary enzyme immunoassay. J Immunoassay Immunochem 2004;25:259–278
- Qui Q, Overstreet JW, Todd H, Nakajima ST, Steward DR, Lasley BL. Total urinary follicle stimulating hormone as a biomarker for detection of early pregnancy and periimplantation spontaneous abortion. Environmental Health Perspectives 1997;105:862–866
- Taussky HH. A microcolorimetric determination of creatinine in urine by the Jaffe reaction. J Biol Chem 1954;208:853–861
- Dufau ML, Winters CA, Hattori M, et al Hormonal regulation of androgen production by the Leydig cell. J Steroid Biochem 1984;20:161–173
- Woods NF, Mitchell ES, Smith-DiJulio K. Cortisol levels across the menopausal transition: observations from the Seattle Midlife Women's Health Study. Menopause 2009;16:708–718
- Brantley PJ, Waggoner CD, Jones GN, Rappaport NB. A Daily Stress Inventory: development, reliability, and validity. J Behav Med 1987;10:61–74
- Pinheiro J, Bates D, DebRoy S, Sarkar D. nlme: Linear and Nonlinear Mixed Effects Models, R package version 3.1, 2005:1–66
- R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing, 2005. http://www. R-project.org
- Sarkar D. Lattice: Lattice Graphics. R package version 0.12–11
- Pinheiro J, Bates D. Mixed-Effects Models in S and S-PLUS. New York: Springer, 2000
- Hox J. Multilevel Analysis: Techniques and Applications. Mahwah, NJ: Lawrence Erlbaum Associates, 2002
- Freeman EW, Sammel MD, Lin H. Temporal associations of hot flashes and depression in the transition to menopause. Menopause 2009;16:728–734
- Joffe H, Soares CN, Thurston RC, et al Depression is associated with worse objectively and subjectively measured sleep, but not more frequent awakenings in women with vasomotor symptoms. Menopause 2009;16:671–679
- Ensrud KE, Stone KL, Blackwell TL, et al Frequency and severity of hot flashes and sleep disturbance in postmenopausal women with hot flashes. Menopause 2008;16:286–292
- Cray L, Mitchell E, Woods N. Symptom clusters during the late menopausal transition stage: observations from the Seattle Midlife Women's Health Study. Menopause 2010; in press
- Shaver JL, Paulsen VM. Sleep, psychological distress, and somatic symptoms in perimenopausal women. Fam Pract Res 1993;13:373–384
- Lentz MJ, Landis CA, Rothermel J, Shaver JL. Effects of selective slow wave sleep disruption on musculoskeletal pain and fatigue in middle aged women. J Rheumatol 1999;26:1586–1592
- Ohayon M. Severe hot flashes are associated with chronic insomnia. Arch Intern Med 2006;166:1262–1268
- Woods NF, Mitchell ES. Sleep symptoms during the menopausal transition and early postmenopause: observations from the Seattle Midlife Women's Health Study. Sleep 2010;33:539–549